# Sleep Number Corp: financial statements, quarterly

SNBRQ · OTC · CIK 827187 · [Materials](/sectors/materials.md) · fiscal year ends Jan 3

Pages: [Overview](/companies/snbrq.md) · [Financials](/companies/snbrq/financials.md) · [Filings](/companies/snbrq/filings.md) · [Insiders](/companies/snbrq/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/snbrq/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [459](/filings/0000827187-24-000071.md) | [473](/filings/0000827187-24-000091.md) | [430 d](/filings/0000827187-26-000014.md) | [470](/filings/0000827187-25-000058.md) | [408](/filings/0000827187-25-000103.md) | [427](/filings/0000827187-25-000121.md) | [377 d](/filings/0000827187-26-000014.md) | [393](/filings/0000827187-26-000041.md) | [328](/filings/0000827187-25-000103.md) | [343](/filings/0000827187-25-000121.md) | [347 d](/filings/0000827187-26-000014.md) | [319](/filings/0000827187-26-000041.md) |
| Cost of revenue | $m | [195](/filings/0000827187-24-000071.md) | [202](/filings/0000827187-24-000091.md) | [187 d](/filings/0000827187-26-000014.md) | [194](/filings/0000827187-25-000058.md) | [167](/filings/0000827187-25-000103.md) | [167](/filings/0000827187-25-000121.md) | [151 d](/filings/0000827187-26-000014.md) | [153](/filings/0000827187-26-000041.md) | [134](/filings/0000827187-25-000103.md) | [137](/filings/0000827187-25-000121.md) | [154 d](/filings/0000827187-26-000014.md) | [134](/filings/0000827187-26-000041.md) |
| Gross profit | $m | [264](/filings/0000827187-24-000071.md) | [271](/filings/0000827187-24-000091.md) | [243 d](/filings/0000827187-26-000014.md) | [276](/filings/0000827187-25-000058.md) | [241](/filings/0000827187-25-000103.md) | [260](/filings/0000827187-25-000121.md) | [226 d](/filings/0000827187-26-000014.md) | [241](/filings/0000827187-26-000041.md) | [194](/filings/0000827187-25-000103.md) | [205](/filings/0000827187-25-000121.md) | [193 d](/filings/0000827187-26-000014.md) | [185](/filings/0000827187-26-000041.md) |
| Research and development | $m | [15.4](/filings/0000827187-24-000071.md) | [12.6](/filings/0000827187-24-000091.md) | [13.3 d](/filings/0000827187-26-000014.md) | [12.4](/filings/0000827187-25-000058.md) | [11.6](/filings/0000827187-25-000103.md) | [10.6](/filings/0000827187-25-000121.md) | [10.7 d](/filings/0000827187-26-000014.md) | [10.9](/filings/0000827187-26-000041.md) | [9.4](/filings/0000827187-25-000103.md) | [7.3](/filings/0000827187-25-000121.md) | [6.3 d](/filings/0000827187-26-000014.md) | [5.3](/filings/0000827187-26-000041.md) |
| Operating income | $m | [11.2](/filings/0000827187-24-000071.md) | [5.4](/filings/0000827187-24-000091.md) | [(19.6) d](/filings/0000827187-26-000014.md) | [5.5](/filings/0000827187-25-000058.md) | [6.1](/filings/0000827187-25-000103.md) | [8.4](/filings/0000827187-25-000121.md) | [2.8 d](/filings/0000827187-26-000014.md) | [1.9](/filings/0000827187-26-000041.md) | [(0.1)](/filings/0000827187-25-000103.md) | [(40.3)](/filings/0000827187-25-000121.md) | [(8.1) d](/filings/0000827187-26-000014.md) | [(36.9)](/filings/0000827187-26-000041.md) |
| Interest expense | $m | [9.9](/filings/0000827187-24-000071.md) | [11.0](/filings/0000827187-24-000091.md) | [12.7 d](/filings/0000827187-26-000014.md) | [12.3](/filings/0000827187-25-000058.md) | [12.3](/filings/0000827187-25-000103.md) | [12.1](/filings/0000827187-25-000121.md) | [11.7 d](/filings/0000827187-26-000014.md) | [11.1](/filings/0000827187-26-000041.md) | [11.7](/filings/0000827187-25-000103.md) | [12.7](/filings/0000827187-25-000121.md) | [13.9 d](/filings/0000827187-26-000014.md) | [13.1](/filings/0000827187-26-000041.md) |
| Income tax | $m | [0.5](/filings/0000827187-24-000071.md) | [(3.3)](/filings/0000827187-24-000091.md) | [(7.1) d](/filings/0000827187-26-000014.md) | [0.7](/filings/0000827187-25-000058.md) | [(1.1)](/filings/0000827187-25-000103.md) | [(0.5)](/filings/0000827187-25-000121.md) | [(4.3) d](/filings/0000827187-26-000014.md) | [(0.6)](/filings/0000827187-26-000041.md) | [13.2](/filings/0000827187-25-000103.md) | [(13.2)](/filings/0000827187-25-000121.md) | [36.6 d](/filings/0000827187-26-000014.md) | [0.3](/filings/0000827187-26-000041.md) |
| Net income | $m | [0.8](/filings/0000827187-24-000091.md) | [(2.3)](/filings/0000827187-24-000091.md) | [(25.2) d](/filings/0000827187-26-000014.md) | [(7.5)](/filings/0000827187-25-000121.md) | [(5.1)](/filings/0000827187-25-000121.md) | [(3.1)](/filings/0000827187-25-000121.md) | [(4.7) d](/filings/0000827187-26-000014.md) | [(8.6)](/filings/0000827187-26-000041.md) | [(25.0)](/filings/0000827187-25-000121.md) | [(39.8)](/filings/0000827187-25-000121.md) | [(58.5) d](/filings/0000827187-26-000014.md) | [(50.3)](/filings/0000827187-26-000041.md) |
| Diluted EPS | $ per share | [0.03](/filings/0000827187-24-000071.md) | [(0.10)](/filings/0000827187-24-000091.md) | not reported | [(0.33)](/filings/0000827187-25-000058.md) | [(0.22)](/filings/0000827187-25-000103.md) | [(0.14)](/filings/0000827187-25-000121.md) | not reported | [(0.38)](/filings/0000827187-26-000041.md) | [(1.09)](/filings/0000827187-25-000103.md) | [(1.73)](/filings/0000827187-25-000121.md) | not reported | [(2.19)](/filings/0000827187-26-000041.md) |
| Basic EPS | $ per share | [0.03](/filings/0000827187-24-000071.md) | [(0.10)](/filings/0000827187-24-000091.md) | not reported | [(0.33)](/filings/0000827187-25-000058.md) | [(0.22)](/filings/0000827187-25-000103.md) | [(0.14)](/filings/0000827187-25-000121.md) | not reported | [(0.38)](/filings/0000827187-26-000041.md) | [(1.09)](/filings/0000827187-25-000103.md) | [(1.73)](/filings/0000827187-25-000121.md) | not reported | [(2.19)](/filings/0000827187-26-000041.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.8](/filings/0000827187-23-000081.md) | [0.9](/filings/0000827187-23-000093.md) | [2.5](/filings/0000827187-25-000018.md) | [2.1](/filings/0000827187-24-000029.md) | [2.0](/filings/0000827187-24-000071.md) | [1.6](/filings/0000827187-24-000091.md) | [2.0](/filings/0000827187-26-000014.md) | [1.7](/filings/0000827187-25-000058.md) | [1.3](/filings/0000827187-25-000103.md) | [1.3](/filings/0000827187-25-000121.md) | [1.7](/filings/0000827187-26-000041.md) | [1.5](/filings/0000827187-26-000041.md) |
| Current assets | $m | [209](/filings/0000827187-23-000081.md) | [198](/filings/0000827187-23-000093.md) | [206](/filings/0000827187-25-000018.md) | [181](/filings/0000827187-24-000029.md) | [177](/filings/0000827187-24-000071.md) | [170](/filings/0000827187-24-000091.md) | [181](/filings/0000827187-26-000014.md) | [175](/filings/0000827187-25-000058.md) | [176](/filings/0000827187-25-000103.md) | [170](/filings/0000827187-25-000121.md) | [150](/filings/0000827187-26-000041.md) | [143](/filings/0000827187-26-000041.md) |
| Total assets | $m | [965](/filings/0000827187-23-000081.md) | [961](/filings/0000827187-23-000093.md) | [951](/filings/0000827187-25-000018.md) | [908](/filings/0000827187-24-000029.md) | [884](/filings/0000827187-24-000071.md) | [865](/filings/0000827187-24-000091.md) | [861](/filings/0000827187-26-000014.md) | [837](/filings/0000827187-25-000058.md) | [805](/filings/0000827187-25-000103.md) | [749](/filings/0000827187-25-000121.md) | [680](/filings/0000827187-26-000041.md) | [641](/filings/0000827187-26-000041.md) |
| Current liabilities | $m | [922](/filings/0000827187-23-000081.md) | [919](/filings/0000827187-23-000093.md) | [936](/filings/0000827187-25-000018.md) | [906](/filings/0000827187-24-000029.md) | [901](/filings/0000827187-24-000071.md) | [894](/filings/0000827187-24-000091.md) | [908](/filings/0000827187-26-000014.md) | [904](/filings/0000827187-25-000058.md) | [903](/filings/0000827187-25-000103.md) | [899](/filings/0000827187-25-000121.md) | [913](/filings/0000827187-26-000041.md) | [932](/filings/0000827187-26-000041.md) |
| Total liabilities | $m | [1,384](/filings/0000827187-23-000081.md) | [1,382](/filings/0000827187-23-000093.md) | [1,393](/filings/0000827187-25-000018.md) | [1,354](/filings/0000827187-24-000029.md) | [1,331](/filings/0000827187-24-000071.md) | [1,313](/filings/0000827187-24-000091.md) | [1,312](/filings/0000827187-26-000014.md) | [1,294](/filings/0000827187-25-000058.md) | [1,285](/filings/0000827187-25-000103.md) | [1,271](/filings/0000827187-25-000121.md) | [1,259](/filings/0000827187-26-000041.md) | [1,267](/filings/0000827187-26-000041.md) |
| Current portion of debt | $m | [484](/filings/0000827187-23-000081.md) | [488](/filings/0000827187-23-000093.md) | [540](/filings/0000827187-25-000018.md) | [524](/filings/0000827187-24-000029.md) | [540](/filings/0000827187-24-000071.md) | [517](/filings/0000827187-24-000091.md) | [547](/filings/0000827187-26-000014.md) | [558](/filings/0000827187-25-000058.md) | [564](/filings/0000827187-25-000103.md) | [580](/filings/0000827187-25-000121.md) | [588](/filings/0000827187-26-000041.md) | [606](/filings/0000827187-26-000041.md) |
| Shareholders' equity | $m | [(419)](/filings/0000827187-24-000091.md) | [(421)](/filings/0000827187-24-000091.md) | [(442)](/filings/0000827187-26-000014.md) | [(446)](/filings/0000827187-25-000121.md) | [(447)](/filings/0000827187-25-000121.md) | [(449)](/filings/0000827187-25-000121.md) | [(452)](/filings/0000827187-26-000041.md) | [(457)](/filings/0000827187-26-000041.md) | [(481)](/filings/0000827187-25-000121.md) | [(521)](/filings/0000827187-25-000121.md) | [(578)](/filings/0000827187-26-000041.md) | [(626)](/filings/0000827187-26-000041.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [0.1 d](/filings/0000827187-24-000071.md) | [13.1 d](/filings/0000827187-24-000091.md) | [(40.8) d](/filings/0000827187-26-000014.md) | [33.7](/filings/0000827187-25-000058.md) | [(10.2) d](/filings/0000827187-25-000103.md) | [27.3 d](/filings/0000827187-25-000121.md) | [(23.7) d](/filings/0000827187-26-000014.md) | [(2.6)](/filings/0000827187-26-000041.md) | [3.8 d](/filings/0000827187-25-000103.md) | [(6.4) d](/filings/0000827187-25-000121.md) | [1.9 d](/filings/0000827187-26-000014.md) | [(7.8)](/filings/0000827187-26-000041.md) |
| Capital expenditure | $m | [14.3 d](/filings/0000827187-24-000071.md) | [18.1 d](/filings/0000827187-24-000091.md) | [9.0 d](/filings/0000827187-26-000014.md) | [9.3](/filings/0000827187-25-000058.md) | [4.8 d](/filings/0000827187-25-000103.md) | [3.1 d](/filings/0000827187-25-000121.md) | [6.3 d](/filings/0000827187-26-000014.md) | [4.6](/filings/0000827187-26-000041.md) | [3.5 d](/filings/0000827187-25-000103.md) | [3.8 d](/filings/0000827187-25-000121.md) | [2.5 d](/filings/0000827187-26-000014.md) | [5.4](/filings/0000827187-26-000041.md) |
| Share repurchases | $m | [0.1 d](/filings/0000827187-24-000071.md) | [0.2 d](/filings/0000827187-24-000091.md) | [0.0 d](/filings/0000827187-26-000014.md) | [0.6](/filings/0000827187-25-000058.md) | [0.0 d](/filings/0000827187-25-000103.md) | [0.1 d](/filings/0000827187-25-000121.md) | [0.0 d](/filings/0000827187-26-000014.md) | [0.6](/filings/0000827187-26-000041.md) | [0.4 d](/filings/0000827187-25-000103.md) | [0.1 d](/filings/0000827187-25-000121.md) | [0.2 d](/filings/0000827187-26-000014.md) | [0.4](/filings/0000827187-26-000041.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-07-02) | Q3 FY2022 (2022-10-01) | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q1 FY2026 (2026-04-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [22.7](/filings/0000827187-23-000081.md) | [22.6](/filings/0000827187-23-000093.md) | [22.6](/filings/0000827187-24-000029.md) | [22.5](/filings/0000827187-24-000071.md) | [22.5](/filings/0000827187-24-000091.md) | [22.5](/filings/0000827187-25-000058.md) | [22.6](/filings/0000827187-25-000103.md) | [22.6](/filings/0000827187-25-000121.md) | [22.7](/filings/0000827187-26-000041.md) | [22.9](/filings/0000827187-25-000103.md) | [23.0](/filings/0000827187-25-000121.md) | [23.0](/filings/0000827187-26-000041.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 23,049,000 at 2026-04-04, from the cover of the [10-Q filed 2026-05-12](/filings/0000827187-26-000041.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.